Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study.
Ruiz-Bañobre J, Molina-Díaz A, Fernández-Calvo O, Fernández-Núñez N, Medina-Colmenero A, Santomé L, Lázaro-Quintela M, Mateos-González M, García-Cid N, López-López R, Vázquez S, Anido-Herranz U. Ruiz-Bañobre J, et al. Among authors: fernandez calvo o. ESMO Open. 2021 Apr;6(2):100090. doi: 10.1016/j.esmoop.2021.100090. Epub 2021 Mar 16. ESMO Open. 2021. PMID: 33740735 Free PMC article.
Follow-up of primary melanoma patients with high risk of recurrence: recommendations based on evidence and consensus.
Campos-Balea B, Fernández-Calvo O, García-Figueiras R, Neira C, Peña-Penabad C, Rodríguez-López C, Vílchez-Simo R, Quindós-Varela M. Campos-Balea B, et al. Among authors: fernandez calvo o. Clin Transl Oncol. 2022 Aug;24(8):1515-1523. doi: 10.1007/s12094-022-02822-x. Epub 2022 Mar 28. Clin Transl Oncol. 2022. PMID: 35349041 Review.
Radium-223 dichloride: a new paradigm in the treatment of prostate cancer.
Anido Herranz U, Fernández Calvo O, Afonso Afonso FJ, Rodríguez Martínez de Llano S, Lázaro Quintela M, León Mateos L, Vázquez Estévez S, Antón Aparicio LM. Anido Herranz U, et al. Among authors: fernandez calvo o. Expert Rev Anticancer Ther. 2015 Mar;15(3):339-48. doi: 10.1586/14737140.2015.999045. Epub 2015 Jan 2. Expert Rev Anticancer Ther. 2015. PMID: 25555355 Free article. Review.
The Challenge of Managing Bladder Cancer and Upper Tract Urothelial Carcinoma: A Review with Treatment Recommendations from the Spanish Oncology Genitourinary Group (SOGUG).
Font A, Luque R, Villa JC, Domenech M, Vázquez S, Gallardo E, Virizuela JA, Beato C, Morales-Barrera R, Gelabert A, Maciá S, Puente J, Rubio G, Maldonado X, Perez-Valderrama B, Pinto A, Fernández Calvo O, Grande E, Garde-Noguera J, Fernández-Parra E, Arranz JÁ. Font A, et al. Among authors: fernandez parra e, fernandez calvo o. Target Oncol. 2019 Feb;14(1):15-32. doi: 10.1007/s11523-019-00619-7. Target Oncol. 2019. PMID: 30694442 Review.
Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.
Climent MÁ, Pérez-Valderrama B, Mellado B, Fernández Parra EM, Fernández Calvo O, Ochoa de Olza M, Muinelo Romay L, Anido U, Domenech M, Hernando Polo S, Arranz Arija JÁ, Caballero C, Juan Fita MJ, Castellano D. Climent MÁ, et al. Among authors: fernandez calvo o, fernandez parra em. Eur J Cancer. 2017 Dec;87:30-37. doi: 10.1016/j.ejca.2017.09.028. Epub 2017 Nov 2. Eur J Cancer. 2017. PMID: 29102858 Clinical Trial.
Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancer.
Fernández Calvo O, Muñoz Iglesias J, Abou Jokh Casas E, Molina-Díaz A, Anido Herranz U, Casas Nebra J, García-Bernardo L, Martínez-Breijo S, Lázaro-Quintela M, Muñiz-García G, Vázquez-Estevez S. Fernández Calvo O, et al. Clin Transl Oncol. 2024 Sep 12. doi: 10.1007/s12094-024-03662-7. Online ahead of print. Clin Transl Oncol. 2024. PMID: 39266875 Review.
Molecular basis of hypertension side effects induced by sunitinib.
Aparicio-Gallego G, Afonso-Afonso FJ, León-Mateos L, Fírvida-Pérez JL, Vázquez-Estévez S, Lázaro-Quintela M, Ramos-Vázquez M, Fernández-Calvo O, Campos-Balea B, Antón-Aparicio LM. Aparicio-Gallego G, et al. Among authors: fernandez calvo o. Anticancer Drugs. 2011 Jan;22(1):1-8. doi: 10.1097/CAD.0b013e3283403806. Anticancer Drugs. 2011. PMID: 20938340 Review.
23 results